Avanafil

Endo International plc (NASDAQ: ENDP) announced in an 8-K filing on Wednesday that it plans on terminating its commercial supply and license agreements with VIVUS, Inc. (NASDAQ: VVUS) related to its right to commercialize Avanafil. Endo International received exclusive rights to commercialize...